Joint Approach

Musculoskeletal Infection Society
  • 0,0 (0)
  • NARAVOSLOVJE

The goal of this podcast is to have both infectious disease physicians and orthopedic surgeons sit down to discuss the “joint” prevention, diagnosis and management of musculoskeletal infections. We break down the existing data and open the lines of communication between the medical and surgical specialties to help navigate these challenging clinical cases.

  1. 21. APR.

    ICM Guidelines Discussion: "Is there a role for Suppressive Antibiotic Treatment only in patients with PJI?” Part 1

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Michael Henry, MD and Daisuke Furukawa, MD in part 1 of this 2-part conversation on the topic of Suppressive Antibiotic Therapy at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

    30 min

  2. 7. APR.

    ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 2

    In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Here are the ICM links: DOCUMENTS | ICMORTHO. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

    28 min

  3. 24. MAR.

    ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 1

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD in part 1 of this 2-part conversation on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

    27 min

  4. 10. MAR.

    Shouldering the Burden: A New Era for Diagnosing Shoulder Prosthetic Joint Infections Part 2

    In the final episode of this 2-part series, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation on Shoulder PJI definition evolution with Surena Namdari, MD, and Jason Hsu, MD. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com.

    29 min

  5. 17. FEB.

    Shouldering the Burden: A New Era for Diagnosing Shoulder Prosthetic Joint Infections Part 1

    Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they chat with Surena Namdari, MD, and Jason Hsu, MD in part 1 of this 2-part conversation on Shoulder PJI definition evolution. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit  bioMérieux.com. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com.

    34 min

  6. 3. FEB.

    Bugged and Baffled: A Case with Meredith Schade and Stephanie Hawkins

    Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Meredith Schade, MD, and Stephanie Hawkins, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

    28 min

  7. 20. JAN.

    Dalbavancin/Oritavancin for treatment of PJI Part 3

    In the conclusion of this series on long-acting antibiotics, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they wrap up the conversation with Vance Fowler,MD, MHS, Thomas Holland, and Thomas Lodise, PharmD, PhD in the first episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproachor Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

    23 min

  8. 6. JAN.

    Dalbavancin/Oritavancin for treatment of PJI Part 2

    Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they continue the in-depth discussion on long-lasting antibiotics with Vance Fowler,MD, MHS, Thomas Holland, and Thomas Lodise, PharmD, PhD in the second episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode.For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

    23 min
Prikaži vse (66)

Več informacij

The goal of this podcast is to have both infectious disease physicians and orthopedic surgeons sit down to discuss the “joint” prevention, diagnosis and management of musculoskeletal infections. We break down the existing data and open the lines of communication between the medical and surgical specialties to help navigate these challenging clinical cases.

Informacije

  • Ustvarjalec
    Musculoskeletal Infection Society
  • Leta delovanja
    2023 - 2026
  • Epizode
    66
  • Ocena
    Primerno za vse
  • Avtorske pravice
    © 2023
  • Spetna stran oddaje
    Joint Approach

Morda vam bo všeč tudi